4.6 Review

SIRT3 regulates progression and development of diseases of aging

Journal

TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 26, Issue 9, Pages 486-492

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2015.06.001

Keywords

mitochondria; sirtuins; SIRT3; aging; disease

Funding

  1. American Heart Association [12SDG8840004, 12IRG9010008]
  2. Friedreich's Ataxia Research Alliance
  3. Ellison Medical Foundation
  4. National Institutes of Health (NIH) [R01AA022146, R01AG045351, R24DK085610-05]
  5. Duke Pepper Older Americans Independence Center (OAIC) Program in Aging Research - National Institute of Aging [P30AG028716-01]
  6. NIH [5T32-CA059365]
  7. NIH/NIGMS [5T32GM007105-40]

Ask authors/readers for more resources

The mitochondrial sirtuin SIRT3 is a protein deacylase that influences almost every major aspect of mitochondrial biology, including nutrient oxidation, ATP generation, reactive oxygen species (ROS) detoxification, mitochondrial dynamics, and the mitochondrial unfolded protein response (UPR). Interestingly, mice lacking SIRT3 (SIRT3K0), either spontaneously or when crossed with mouse models of disease, develop several diseases of aging at an accelerated pace, such as cancer, metabolic syndrome, cardiovascular disease, and neurodegenerative diseases, and, thus, might be a valuable model of accelerated aging. In this review, we discuss functions of SIRT3 in pathways involved in diseases of aging and how the lack of SIRT3 might accelerate the aging process. We also suggest that further studies on SIRT3 will help uncover important new pathways driving the aging process.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available